Saturday 7 November 2026 Export ELAB’s income statement to Excel — free account

PMGC Holdings Inc.

ELAB Healthcare Biotechnology

PMGC Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $590,100.00, down 65.5% from fiscal 2023.

Revenue: +147.7%
EPS: +98.4%
Free cash flow: −45.0%

Quarter to June 2026, against a year earlier

1.61 0.04 −2.42%

Follow ELAB

Alert me

Market cap: $1.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: −3.65
Beneish M: n/a
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	2.29	1.48	0.79	1.37
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(2.97)	(0.89)	(0.77)	(1.87)
P/B ratio Full definition →	0.35	0.21	0.17	0.33
Price to Tangible BV Full definition →	0.77	0.38	0.34	0.56
EV/Sales Full definition →	(4.89)	(6.70)	(2.63)	(2.55)
EV/EBITDA Full definition →	1.12	1.38	0.67	0.85
EV/Operating CF Full definition →	1.54	1.59	0.76	0.84
EV/FCF Full definition →	1.40	1.44	0.71	0.79
Quick Ratio Full definition →	1.27	1.38	1.60	1.62
Current Ratio Full definition →	1.36	1.45	1.74	1.79
Net Debt/EBITDA Full definition →	5.26	4.66	2.45	3.93
Debt/Assets Full definition →	0.75%	1.38%	0.66%	0.00%
Debt/Equity Full definition →	0.02	0.03	0.01	0.00
Asset Turnover Full definition →	0.11	0.10	0.16	0.16
Operating CF/Net income Full definition →	0.68	0.60	0.59	0.57
Capex/Depreciation Full definition →	0.09	(2.09)	(5.80)	(2.71)
Interest Coverage Full definition →	(6.57)	(7.03)	(10.73)	(126.37)
Research and Development Expense of Revenue Full definition →	23.74%	6.91%	10.82%	5.25%
Selling, General and Administrative Expense of Revenue Full definition →	124.80%	207.64%	329.43%	276.67%
Intangible Assets out of Total Assets Full definition →	0.25	0.22	0.30	0.23
Share Based Compensation of Revenue Full definition →	13.36%	1.20%	3.49%	4.62%
Graham Net Nets Full definition →	0.17	1.11	1.36	1.19
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(17,180.78%)	(4,091.35%)	(1,356.08%)	(780.00%)
Free Cash Flow Yield Full definition →	(152.40%)	(314.29%)	(471.64%)	(235.80%)
Revenue per Share Full definition →	2.68	15.33	79.82	129.95
Operating CF per Share Full definition →	(4.08)	(66.96)	(459.35)	(677.36)
Capex per Share Full definition →	0.06	(8.16)	(91.00)	(43.45)
Free Cash Flow per Share Full definition →	(4.02)	(75.12)	(550.35)	(720.82)
Cash per Share Full definition →	38.54	339.05	1,568.19	3,865.73
Shareholders Equity per Share Full definition →	34.33	283.29	2,057.20	3,859.41
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	34.33	283.29	2,057.20	3,859.41
Free Cash Flow Full definition →	(1.96)	(3.34)	(2.10)	(1.59)
Working Capital Full definition →	5.50	5.09	2.93	4.31
Capital Expenditures Full definition →	0.03	(0.36)	(0.35)	(0.10)
Net Current Asset Value Full definition →	1.01	2.96	1.84	3.33
EV/EBIT Full definition →	1.07	1.34	0.66	0.85
Capex to Sales Full definition →	(0.02)	0.53	1.14	0.33
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.34	0.30	0.17	0.20
Average Payables Full definition →	0.77	0.52	0.59	0.89
Average Inventory Full definition →	0.96	0.62	0.52	0.31
Average Assets Full definition →	22.97	17.46	10.93	13.07
Average Common Equity Full definition →	12.89	10.37	7.25	8.52

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly